Showing 1 - 6 results of 6 for search 'James D Neaton', query time: 0.02s Refine Results
  1. 1
    Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.

    Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy. by Birgit Grund, Jason V Baker, Steven G Deeks, Julian Wolfson, Deborah Wentworth, Alessandro Cozzi-Lepri, Calvin J Cohen, Andrew Phillips, Jens D Lundgren, James D Neaton, INSIGHT SMART/ESPRIT/SILCAAT Study Group

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

    Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. by Lewis H Kuller, Russell Tracy, Waldo Belloso, Stephane De Wit, Fraser Drummond, H Clifford Lane, Bruno Ledergerber, Jens Lundgren, Jacqueline Neuhaus, Daniel Nixon, Nicholas I Paton, James D Neaton, INSIGHT SMART Study Group

    Published 2008-10-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease.

    Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease. by Lotty Ledwaba, Jorge A Tavel, Paul Khabo, Patrick Maja, Jing Qin, Phumele Sangweni, Xiao Liu, Dean Follmann, Julia A Metcalf, Susan Orsega, Beth Baseler, James D Neaton, H Clifford Lane, Project Phidisa Biomarkers Team

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project Phidisa.

    Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project Phidisa. by Patrick H Maduna, Matt Dolan, Lwando Kondlo, Honey Mabuza, Judith N Dlamini, Mike Polis, Thabo Mnisi, Susan Orsega, Patrick Maja, Lotty Ledwaba, Thuthukile Molefe, Phumelele Sangweni, Lisette Malan, Gugu Matchaba, Paul Khabo, Greg Grandits, James D Neaton

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.

    Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy. by Christopher J Miller, Jason V Baker, Alison M Bormann, Kristine M Erlandson, Katherine Huppler Hullsiek, Amy C Justice, Jacqueline Neuhaus, Roger Paredes, Kathy Petoumenos, Deborah Wentworth, Alan Winston, Julian Wolfson, James D Neaton, INSIGHT SMART Study Group, ESPRIT Study Group

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.

    The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. by Richard T Davey, Ruth Lynfield, Dominic E Dwyer, Marcello H Losso, Alessandro Cozzi-Lepri, Deborah Wentworth, H Clifford Lane, Robin Dewar, Adam Rupert, Julia A Metcalf, Sarah L Pett, Timothy M Uyeki, Jose Maria Bruguera, Brian Angus, Nathan Cummins, Jens Lundgren, James D Neaton, INSIGHT FLU 002 & 003 Study Groups

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: